Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma

Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The two screenshots show the same Study Details page (NCT03430791) with identical sections such as Brief Summary, Eligibility, Interventions, and Study Dates; no additions or deletions detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T17:46:37.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    Major addition: a prominent operating-status notice for users and a v3.2.0 release tag replaces the prior v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:55:42.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:16:01.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page updated to revision v3.0.2 (from v3.0.1), and the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T21:31:15.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T17:38:38.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as various types of proteins and antibodies, while removing several disease-related terms and previous location details.
    Difference
    2%
    Check dated 2025-08-31T12:18:29.000Z thumbnail image

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.